Sage Journals: Discover world-class research

Abstract

Background: Obesity and modifiable lifestyle factors contribute significantly to the rising global burden of cancer, particularly gynecologic malignancies such as endometrial and ovarian cancer. Despite strong biological plausibility, the role of lifestyle interventions in improving outcomes for women with gynecologic cancers remains underexplored. Objective: This review synthesizes current evidence on the impact of dietary and physical activity interventions on gynecologic cancer outcomes, highlighting links and existing clinical guidelines. Methods: Literature exploring the influence of obesity, inflammation hormonal dysregulation, insulin resistance, and gut microbiome alterations on cancer progression were assessed, and studies assessing the effects of lifestyle interventions in gynecologic cancers were explored. Results: Obesity-induced inflammation and hormonal imbalances are key drivers of tumorigenesis. Structured exercise and adherence to anti-inflammatory diets, such as the Mediterranean diet, can reduce pro-inflammatory cytokines, improve insulin sensitivity, regulate estrogen metabolism, and enhance immune function. These interventions also modulate angiogenesis and promote a favorable gut microbiome, offering a biologically plausible approach to slowing cancer progression. Conclusion: Diet and exercise represent promising, low-risk strategies to improve quality of life and potentially enhance survival in women with gynecologic cancers. Greater integration of lifestyle interventions into gynecologic oncology care is warranted, guided by evidence and recommendations from national cancer organizations.

Keywords

ovarian cancer endometrial cancer lifestyle nutrition diet exercise

“Lifestyle factors play a critical role in the development, possible progression and growing incidence of many cancers, especially endometrial and ovarian cancer.”

Introduction

Cancer remains the second leading cause of death worldwide with 20 million newly diagnosed cancer cases and 9.7 million deaths from cancer reported in 2022. The incidence of cancer continues to rise and is expected to reach 35 million cases by 2050.¹ This increase is largely driven by population growth and modifiable lifestyle factors such as diet, physical inactivity, smoking, and obesity. Specifically, obesity is a significant contributor to cancer-related mortality. Among women with a body mass index greater than 40, the risk of death from all cancers is 60% higher than that for women with normal BMI.

Obesity is a predominant risk factor in gynecologic cancers, especially in endometrial cancer, influencing both cancer development and prognosis. Despite these known associations, the role of lifestyle interventions, including dietary and physical activity modifications in improving outcomes for gynecologic cancer patients remains underexplored. This review synthesizes current knowledge on the impact of lifestyle interventions on ovarian and endometrial cancer outcomes. We explore mechanistic links, evaluate existing guidelines, and discuss evidence from other cancer types to offer insights into enhancing the care of women with gynecologic cancers through lifestyle intervention.

Mechanistic Links Between Lifestyle Factors and the Development of Gynecologic Cancers

Lifestyle factors influence cancer development and progression through complex biological mechanisms, including inflammation, angiogenesis, hormonal regulation, insulin resistance, and gut microbiome modulation. Understanding these pathways is critical to leveraging lifestyle interventions as an integral part of gynecologic cancer care.

Obesity, Inflammation and Immune Function

Obesity creates a pro-inflammatory state through the secretion of adipose tissue-derived cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6).² These inflammatory mediators contribute to tumor progression by promoting cancer cell proliferation and survival. Chronic inflammation associated with obesity is a well-established driver of endometrial and ovarian cancer.² On the other hand, exercise can reduce inflammation and improve immune surveillance.³ In a study that investigated the effects of exercise on inflammatory markers in patients with ovarian cancer, those who engaged in regular exercise exhibited significantly lower levels of pro-inflammatory cytokines, such as IL-6 and TNF-α.⁴ Furthermore, a metanalysis found that cancer patients who adhered to a Mediterranean diet rich in fruits, vegetables, and healthy fats, had significantly lower levels of inflammatory markers IL-6 and TNF-α compared to a standard diet.⁵ These factors may create a more favorable environment to inhibit tumor growth and potentially mitigate tumor progression.

A combined exercise and dietary program in breast cancer survivors showed that participants in the intervention group had a 20% increase in natural killer (NK) cell activity and a 15% increase in the CD8⁺ T cell population, compared to the control group.³ In another study, participation in a structured exercise and nutrition program correlated with a higher rate of pathologic complete response during neoadjuvant chemotherapy for breast cancer.⁶ As such, engaging in exercise has been shown to mitigate the inflammatory effects of obesity and enhance immune function.

Angiogenesis

Diets rich in high fat and sugar elevate the levels of vascular endothelial growth factor (VEGF) that fuels tumor growth.⁷ Similarly, an increase adipose tissue leads to the secretion of adipokines and cytokines (e.g., leptin and interleukin-6), which further stimulate angiogenesis and create a tumor-promoting microenvironment.^8-10 Excess adipose tissue also serves as a source of aromatase activity, leading to increased conversion of androgens to estrogens, which can promote the proliferation of estrogen-sensitive tissues and enhance angiogenic signaling pathways.¹¹ This increase in circulating estrogens, along with inflammatory cytokines, increases the susceptibility to gynecologic cancers such as endometrial and ovarian cancers.

On the other hand, a diet rich in fruits, vegetables, and whole grains, which are abundant in anti-inflammatory and anti-angiogenic compounds, can inhibit angiogenesis. For example, polyphenols found in green tea, resveratrol in red wine, and curcumin in turmeric have been identified as potent inhibitors of angiogenesis, exerting their effects by downregulating VEGF and other angiogenic factors.^12-14 Regular physical activity can also have a profound impact on the regulation of angiogenic factors. Exercise has been shown to reduce the expression of VEGF and other pro-angiogenic markers in both adipose tissue and systemic circulation in animal models.¹⁵ Therefore, angiogenesis is a key driver of tumor growth under the effects of obesity, while a balanced diet and regular physical activity can provide antiangiogenetic benefits.

Hormonal Regulation and Insulin Resistance

Obesity-induced hyperestrogenism is a key driver of carcinogenesis in both endometrial cancer and ovarian cancer.¹⁶ Dietary fiber, particularly insoluble fiber, which is found in whole grains and vegetables, binds to estrogens in the intestinal lumen.¹⁶ This binding prevents estrogen reabsorption in the enterohepatic circulation, promoting excretion via feces.¹⁶ As a result, circulating estrogen levels decrease, which may reduce estrogen-driven proliferation of endometrial cancer. A meta-analysis by Bandera et al¹⁷ (2008)¹⁷ reported an inverse association between fiber consumption and endometrial cancer risk, suggesting that a high-fiber diet may mitigate the effects of elevated estrogen levels in obese individuals. Similar findings were noted in ovarian cancer patients suggesting the protective role of dietary fiber in regulating estrogen metabolism.¹⁷

Hyperinsulinemia exacerbates ovarian and endometrial cancer cell growth by activating the PI3K/Akt signaling pathway and promoting systemic inflammation.^18,19 Hyperinsulinemia also suppresses the production of sex hormone-binding globulin (SHBG), leading to increased levels of free estrogen, which stimulates endometrial cell proliferation.²⁰ Alternatively, lifestyle changes, such as rigorous exercise and dietary programs exercise, along with pharmacologic agents, such as metformin can reduce hyperinsulinemia and improve insulin sensitivity, disrupting tumor-promoting pathways.²⁰ In a breast cancer cohort, reducing insulin-like growth factor 1 (IGF-1) through lifestyle modifications such as engaging in structured aerobic exercise, adhering to a low-glycemic or Mediterranean diet, and incorporating metformin therapy enhanced tumor chemosensitivity, ultimately inhibiting cancer cell proliferation and metastasis.²¹

The Gut Microbiome

The gut microbiome, the collection of the microorganisms residing in the intestines, has emerged as a critical factor influencing cancer development and progression. The gut microbiome interacts with the immune system and can influence systemic inflammation, which modulates cancer growth. Additionally, certain gut bacteria can modulate the metabolism of estrogens and other hormones, impacting hormone-driven cancers such as endometrial cancer.²² A diet high in fiber and low in processed foods promotes a diverse and balanced microbiome, which can produce short-chain fatty acids (SCFAs) which have anti-inflammatory and anti-cancer properties.^23,24 Conversely, a diet high in fat and sugar can disrupt the microbiome, leading to dysbiosis and the production of toxic metabolites that can promote inflammation and cancerous proliferation.²⁵ Modulating the microbiome through diet offers a promising avenue for reducing cancer progression.

Overview of Current Guidelines on Lifestyle Interventions in Patients with Cancer

Leading organizations, including the American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN), have emphasized the importance of lifestyle interventions as part of comprehensive cancer care. Their recommendations center on maintaining a healthy weight, engaging in regular physical activity, and adhering to a balanced diet.²⁶ Lifestyle interventions that include diet and exercise during and after cancer treatment can improve quality of life, reduce chemotherapy toxicity, maintain healthy body weight and composition, and potentially enhance survival.^26-28

Dietary Recommendations

Cancer-directed treatments can be associated with muscle wasting and immunosuppression.²⁹ Thus, adequate protein intake is recommended for maintaining muscle mass and strength during cancer treatment.³⁰ The ACS guidelines also advise limiting the intake of processed foods and red meats, refined grains, and sugars, which are linked to inflammation and adverse cancer treatment outcomes.²⁶ Omega-3 fatty acids, found in fatty fish and flaxseeds, provide anti-inflammatory effects, which may help mitigate cancer progression and improve treatment tolerance.^30,31 However, the evidence on their benefits during chemotherapy is limited.

Exercise Recommendations

Exercise has been shown to alleviate treatment-related side effects such as fatigue, anxiety, and depression, thereby improving the overall quality of life for cancer patients.^32,33 According to the ACS guidelines, moderate-intensity aerobic exercise, such as brisk walking, cycling, or swimming, for at least 150 minutes per week, is recommended for cancer patients.³⁴ Stretching exercises as well as resistance training exercises should be incorporated at least 2 days each week. Resistance training in the form of weightlifting or bodyweight exercises (e.g., squats, lunges, push-ups) can help preserve muscle mass and strength during treatment.³⁵

Weight Management Recommendations

Weight management is a cornerstone of survivorship and supportive care. Strategies to achieve and maintain healthy weight should be multicomponent, integrating dietary modification, structured physical activity, and behavioral counseling. Intensive behavioral programs, typically involving ≥12 sessions within the first year, achieve clinically meaningful weight loss of 5-10% within 6-12 months, with approximately 40% of participants in gynecologic oncology cohorts attaining ≥5% weight loss at 6 months.^36,37 Core behavioral strategies, including self-monitoring, goal-setting, problem solving, and relapse-prevention follow-up, are critical for sustaining results. Weight loss typically plateaus after 6 months due to metabolic adaptation, so ongoing support and maintenance strategies are critical.

Benefits of Lifestyle Interventions in Gynecologic Cancer Care and Current Evidence

Lifestyle interventions provide multiple benefits across the cancer care continuum from prevention to treatment and survivorship, improving physical, psychological, and treatment-related outcome.

Cancer Prevention Benefits

The risk of progression from endometrial hyperplasia to carcinoma is significantly influenced by various lifestyle factors. Interventions such as weight loss and regular physical activity, defined in studies by roughly 30 minutes of moderate-intensity cardiac and musculoskeletal activity 5 days a week, can play a crucial role in mitigating this risk by reducing estrogen levels, decreased chronic inflammation and improving insulin sensitivity.³⁸ A study by Rundle-Thiele et al, (2022)³⁹ investigating the impact of lifestyle interventions on the risk of progression from endometrial hyperplasia to carcinoma found that an intervention consisting of diet, physical activity and bariatric surgery was associated with favorable changes in endometrial cancer biomarkers, such as reduced endometrial proliferation (measured by Ki-67), increased adiponectin, and reduced circulating insulin levels.³⁹ A recent meta-analysis similarly concluded that weight loss and physical activity are effective strategies for reducing the risk of endometrial hyperplasia progression to carcinoma.⁴⁰ The authors note that physical activity and weight loss are associated with improved quality of life in endometrial and ovarian cancer survivors, and that small interventional trials show promise for increasing physical activity and weight maintenance.⁴⁰ Furthermore, in a population-based cohort study by Mooreman et al, regular physical activity was associated with a reduction in ovarian cancer risk particularly among women engaging in at least 150 minutes of moderate-intensity exercise per week.⁴¹

Cancer Treatment Benefits

Chemotherapy-Related Adverse Events and Toxicities

Physical activity can alleviate chemotherapy-induced fatigue, nausea, and neuropathy.^42,43 Mustian et al found that exercise interventions produced a mean weighted effect size (WES) of 0.30 (95% CI, 0.25-0.36) for reducing cancer-related fatigue, which is a moderate effect. Breast, GI, colon, and multiple myeloma cancer patients demonstrated chemotherapy-induced peripheral neuropathy (CIPN), and reported that a structured exercise program led to modest reductions in CIPN symptoms (e.g., a mean reduction of 0.42-0.46 points on a 0-10 scale for numbness/tingling and hot/coldness, respectively).⁴⁴ Hence, exercise and dietary interventions can help reduce the toxicity and side effects associated with chemotherapy.

Improvement in Nutrition

Nutritional support can prevent weight loss and malnutrition, which are common side effects of chemotherapy, thus improving patients’ ability to complete their treatment regimens.⁴⁵ The prevalence of malnutrition in cancer patients at the time of first medical oncology visit is 51%, with 9% overtly malnourished and 43% at risk for malnutrition. This study also found that 64% of patients had experienced weight loss (between 1-10 kg) in the previous 6 months and over 40% reported anorexia. The severity of malnutrition correlated with advanced cancer stage.^45,46 Therefore, integration of dieticians within oncology teams to develop personalized nutrition plans that address the specific needs of cancer patients, is highly beneficial.

Psychological and Quality of Life Benefits

Regular physical activity provides ample mental health benefits. A review by Wanjau et al⁴² (2023) found that individuals with high physical activity levels had a 17% lower risk of incident depression and a 26% lower odds of developing anxiety) compared to those with low activity.⁴² Furthermore, a study published in Gynecologic Oncology found that patients undergoing treatment for endometrial cancer who participated in a structured exercise program experienced less fatigue and improved physical functioning compared to those who did not exercise.⁴³ Therefore, exercise plays a key role in alleviating anxiety and depression in patients undergoing cancer treatment.

Cancer Survivorship Benefits

Lifestyle modifications after treatment can potentially contribute to reducing reduce recurrence rates and improve survival.⁴⁷ The recently published CHALLENGE trial was a phase 3, multi-center, randomized study that enrolled 889 patients with resected colon cancer who had completed adjuvant chemotherapy, assigning them to either a 3-year structured exercise program or health-education materials alone, with disease-free survival as the primary endpoint. The trial demonstrated that the structured exercise intervention significantly improved disease-free survival (hazard ratio 0.72, 95% CI 0.55-0.94; P = 0.02) and was associated with longer overall survival (hazard ratio 0.63, 95% CI 0.43-0.94), supporting the role of sustained exercise in improving oncologic outcomes after chemotherapy.⁴⁸ Ovarian cancer survivors adhering to high-fiber, low-fat diets and regular exercise reported better overall health and reduced fatigue.⁴⁷ Additionally, Thomson et al, 2023⁴⁷ tested whether a combined diet and physical activity intervention improves progression-free survival in ovarian cancer survivors. While complete results of this study are not yet reported, for ovarian cancer survivors in this study, a mean daily intake of 6.6 servings of fruits and vegetables, 62.7 grams of fat, and 21.7 grams of fiber was reported. Participants averaged 13.0 metabolic equivalent task-hours per week of moderate to vigorous physical activity and spent 50.9 hours per week sedentary, with retention rates exceeding 88% over the course of the intervention. Literature shows a vast lack of high-quality clinical trials demonstrating definitive survival or recurrence benefits from lifestyle interventions in breast cancer. A summary of available studies is presented in Table 1.^39,40,49,50

Table 1.

Benefits of Lifestyle Interventions in Gynecologic Cancer Studies

Study (Author, Year)	Type of Study	Population	Intervention	Outcome Measured	Key Findings
Rundle-Thiele et al, 2022	Systematic review	Women with endometrial hyperplasia or at increased risk for endometrial cancer	Weight management including dieting and bariatric surgery and physical activity	Changes in endometrial cancer biomarkers (Ki-67, adiponectin, insulin); risk reduction not quantified	Lifestyle interventions may reduce endometrial proliferation and improve metabolic biomarkers
Beavis et al, 2016	Narrative review	Women with endometrial hyperplasia or at risk for endometrial cancer	Weight loss including bariatric surgery and regular physical activity	Risk of endometrial hyperplasia progressing to carcinoma	30% reduced risk of progression from endometrial hyperplasia to carcinoma with weight loss and regular physical activity; strongest effect seen with bariatric surgery
Moorman et al, 2011	Population-based case-control study	General female population in North Carolina; 638 epithelial ovarian cancer cases with 683 controls	≥150 minutes/week moderate-intensity recreational physical activity (self-reported average activity at various time periods)	Risk of ovarian cancer; survival among cases	Modestly reduced risk of ovarian cancer in some activity categories, but no consistent dose-response; no statistically significant association for ≥150 min/week vs less active. Among non-obese women with ovarian cancer, >2 hour/week activity pre-diagnosis associated with improved survival (HR = 0.69, 95% CI: 0.47-1.00) compared to <1 hour/week
Nagle et al, 2025	Pooled analysis of observational cohort studies	7700 women with invasive epithelial ovarian cancer (13 studies pooled; global, multi-center; pre-diagnosis dietary data via FFQ)	Adherence to healthy dietary patterns prior to diagnosis (alternate Healthy Eating Index, Healthy Eating Index-2015, alternate Mediterranean diet, and intake of specific foods such as vegetables, tomatoes, nuts/seeds)	Overall survival (OS), stratified by tumor stage	Early stage disease: higher adherence to healthy dietary patterns was associated with improved OS. Higher intake of vegetables, tomatoes, and nuts/seeds) also associated with better OS. No consistent associations in advanced-stage disease
Thomson et al, 2023	Phase III randomized control trial	Ovarian cancer survivors	Regular physical activity (≥150 minutes/week moderate intensity) compared to less active and inactive controls	Cancer recurrence, cancer-specific mortality	Outcomes not yet reported
Hansen et al, 2020	Prospective cohort study	678 Australian women with invasive epithelial ovarian cancer; 512 with post-treatment HLI	Healthy Lifestyle Index (HLI) based on smoking, BMI, physical activity, diet, alcohol; assessed pre- and post-diagnosis	All-cause mortality (Cox regression, HRs for HLI tertiles and individual lifestyle factors)	Post-diagnosis: Highest HLI tertile had significantly better survival than lowest (HR 0.61, 95% CI: 0.40-0.93; P-trend = .02). Higher post-diagnosis physical activity associated with better survival (HR 0.60, 95% CI: 0.39-0.92; P-trend = .02)

Challenges and Future Directions: The Tenets and Feasibility of Lifestyle Interventions

While lifestyle interventions offer a broad spectrum of benefits in managing symptoms and improving outcomes in gynecologic cancer care, notable gaps in knowledge remain.⁵¹ The mechanisms by which lifestyle factors influence specific tumor microenvironments and recurrence rates require further investigation.^52,53 Addressing these gaps through robust clinical trials and longitudinal studies will help refine evidence-based guidelines and maximize the therapeutic potential of lifestyle interventions in gynecologic oncology.

Furthermore, clarifications regarding the optimal exercise and diet regimens, the frequency, intensity, and type of exercise for specific cancer types, including ovarian and endometrial cancers, are needed.²⁸ This lack of clarity hampers the ability to provide evidence-based, individualized recommendations for patients at this time. A critical barrier to advancing the field is the lack of large, well-controlled clinical trials investigating lifestyle interventions as adjunctive cancer therapies. Many studies to date have relied on observational data, which are inherently limited by confounding variables such as socioeconomic status and access to health care.⁵⁴ Thus, prospective randomized controlled trials are needed to determine causal relationships, establish evidence-based guidelines, and address variability in individual responses to diet and exercise interventions.⁵⁵

Lifestyle Intervention through the Lens of Behavioral Adherence Model

A significant barrier to implementing lifestyle interventions in cancer care is behavioral resistance, as modifying established habits and adopting new behaviors can be particularly challenging for patients facing life-altering diagnoses. The behavioral adherence models provide a framework for understanding and promoting lifestyle interventions among patients, particularly those dealing with chronic conditions like cancer (Figure 1). Key tenets of these models include self-efficacy, goal-setting, social support, and the Transtheoretical Model of behavior change.⁵⁶ Self-efficacy, the belief in one’s ability to execute specific behaviors, is crucial for initiating and maintaining lifestyle changes.^57,58 Goal-setting helps patients create clear, attainable objectives, which can increase motivation and adherence. Social support from family, friends, and health care providers plays a significant role in encouraging and sustaining healthy behaviors.^56,59

Figure 1.

Behavioral adherence model

The Transtheoretical Model (TTM) which categorizes behavior change into stages—precontemplation, contemplation, preparation, action, and maintenance—can guide the implementation of lifestyle interventions.⁵⁶ By identifying the patient’s current stage, interventions can be tailored to meet their specific needs, enhancing their feasibility and effectiveness. For instance, patients in the contemplation stage may benefit from educational resources and motivational interviewing to increase their readiness for change, while those in the action stage may need more practical support, such as exercise plans or dietary counseling.⁶⁰

Example components supported by the literature include: (1) a 10-20 minute motivational interviewing visit focused on ambivalence and readiness; (2) weekly stage-matched modules or counseling sessions; (3) daily feedback from wearable devices to support self-monitoring; (4) SMS prompts for meal or activity logging; and (5) monthly relapse-prevention calls during maintenance. These strategies are consistent with the processes of change and have been shown to facilitate movement through the TTM stages, improve behavioral outcomes, and support maintenance of healthy behaviors in oncology and other clinical populations.⁶¹

The American Society of Clinical Oncology and the American Cancer Society advise offering intensive, multicomponent behavioral programs, typically ≥12 sessions in the first year, targeting 5-10% weight loss over 6-12 months and maintenance thereafter.^62-64

Comprehensive lifestyle modification interventions that combine dietary change, increased physical activity, and behavioral counseling have been studied are recommended for weight management in gynecologic oncology. Trials from von Gruenigen’s group established feasibility, adherence, and patient-centered benefits of multicomponent lifestyle programs in obese endometrial cancer survivors. In a randomized trial, participants in the intervention arm achieved sustained weight loss with improved diet and activity; quality-of-life gains were mediated by behavioral change constructs (self-efficacy), confirming a plausible mechanism of benefit. Subsequent reports from the same program (including SUCCEED) documented high adherence, durable behavior change, and clinically meaningful weight reduction over 6-12 months, supporting integration into routine follow-up.^65,66 Complementing this, a recent real-world implementation by Morris and colleagues showed that a remotely delivered, group-based lifestyle modification intervention embedded in gynecologic oncology practice is feasible across urban/rural settings and yields statistically and clinically significant weight loss of 4.2 kg with 40% of patients attaining ≥5% weight loss at 6 months.⁶⁷

Despite these benefits, current evidence does not demonstrate improvements in overall survival or recurrence, largely due to limited sample sizes and short follow-up.^68-70 However, interventions are safe, improve cardiometabolic risk factors, and address cardiovascular disease—a major contributor to mortality in this population. Effective programs typically include a 500-750 kcal/day energy deficit, individualized dietary patterns, ≥150 minutes/week of moderate aerobic activity, and behavioral strategies such as self-monitoring and goal-setting. Barriers include limited provider training and patient support needs, highlighting the importance of multidisciplinary care and tailored interventions.^68,69

The Role of Digital Health Technologies

Studies have shown that the Transtheoretical Model is particularly effective in promoting dietary changes and physical activity among cancer survivors.⁵⁶ Roberts et al reported that multiple studies have found that the Transtheoretical Model-based interventions moderately improved exercise adherence and dietary habits among breast cancer patients.⁷⁰ These interventions, which included personalized feedback, stage-matched counseling, and follow-up support, helped patients progress through the stages of change, leading to sustained behavior modifications.⁷⁰

Multicomponent interventions, including self-monitoring, goal-setting, and social support, yield the best results for exercise and diet adherence, especially when combined with digital tools like mobile apps and wearables.^71-73 A systematic review found that interventions incorporating self-monitoring, goal-setting, and social support were most effective in promoting long-term adherence to physical activity and dietary changes.⁷⁴ Programs that used technology, such as mobile apps and wearable devices for tracking progress, also showed promising results in enhancing self-monitoring and accountability.⁷⁵ Overall, behavioral adherence models that emphasize personalized, stage-specific strategies, and incorporate elements of self-efficacy, social support, and technology-enhanced self-monitoring appear to be most effective in promoting and maintaining healthy lifestyle changes among patients.^71,72

Barriers to Implementation

The variability in individual motivation and readiness to change is a significant barrier in implementing lifestyle interventions. Patients at different stages of the TTM require tailored interventions, yet health care systems often lack the resources to provide such personalized support.⁵⁶ Additionally, socioeconomic factors, such as limited access to healthy foods and safe environments for physical activity, can hinder the adoption and maintenance of healthy behaviors.^76,77 As a result, individuals from lower socioeconomic backgrounds may struggle to progress through the Transtheoretical Model stages, potentially leading to poorer health outcomes and increased cancer risk. Addressing these disparities by providing tailored interventions, reducing financial and structural barriers, and increasing accessibility to resources is essential for improving outcomes for patients with gynecologic cancers.⁷⁸ While technology-enhanced interventions show promise, they may not be accessible to all patients, particularly older adults or those from lower socioeconomic backgrounds.⁷⁷

Sustainability and Scalability

Promoting lifestyle interventions through behavioral adherence models necessitates personalized, scalable, and sustainable solutions. Ensuring continued engagement and adherence requires ongoing support and reinforcement, which can be resource intensive.⁷⁹ A meta-analysis by Stecher et al⁸⁰ (2023) demonstrated that mobile health interventions significantly improve physical activity and dietary behaviors, with adherence enhanced by features like reminders and gamification.⁸⁰

Digital health technologies offer significant potential in this regard. Mobile applications like MyFitnessPal and CancerFit facilitate dietary tracking and exercise regimens tailored to cancer patients, enhancing adherence and improving health outcomes.⁸¹ Wearable devices, such as Fitbit, provide real-time activity feedback and have been shown to increase physical activity among cancer survivors.⁸²

Furthermore, telehealth platforms enable remote consultations for nutritional counseling and behavioral coaching, with systematic reviews indicating their effectiveness in improving dietary behaviors.⁸³ Integrating behavioral adherence models, such as the Transtheoretical Model, into these technologies can tailor interventions based on a patient’s readiness to change. Community-based digital programs like MyFoodDiary foster social support, which enhances adherence to lifestyle changes.^84,85 Together, these innovative approaches empower cancer patients to maintain healthy behaviors and improve treatment outcomes through continuous, personalized support. While the integration of lifestyle interventions into routine cancer care is still evolving, there is a need for more standardized protocols and training for health care providers to effectively support behavior change.

Conclusions

Lifestyle factors play a critical role in the development, possible progression and growing incidence of many cancers, especially endometrial and ovarian cancer. The evidence shown in this review underscores the significant benefits of regular physical activity in reducing the risk of recurrence, improving quality of life and potentially improving survival rates. Despite this evidence, lifestyle interventions are often a neglected component in patient counseling and survivorship, and the implementation of these interventions is often nonuniform and limited in scope. Our findings highlight the need for increased investment in incorporating lifestyle interventions into routine gynecologic cancer care and investment in randomized controlled trials that investigate the cancer-specific benefits of these interventions.

Future directions in promoting lifestyle interventions through behavioral adherence models should focus on personalized, scalable, and sustainable solutions such as digital health technologies. Finally, greater value and time should be placed in creating preventative measures to improve outcomes and decrease risks allowing patients the best chance at a good quality of life. More in-depth research in endometrial cancer and other understudied gynecologic cancers should be emphasized to create more informed and personalized health and lifestyle improvements for patients.

Addressing modifiable lifestyle factors by integrating targeted exercise and dietary modifications into patient care, represents a pivotal frontier in enhancing outcomes for women battling gynecologic cancers. Empowering patients with tools to optimize their health and motivating compliance with a healthy lifestyle during and after treatment can potentially augment therapeutic outcomes and redefine standards of survivorship in gynecologic oncology.

Footnotes

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

ORCID iD

Mariam Alhilli

References

Bray

Laversanne

Sung

, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi:10.3322/caac.21834

Shi

Zhu

Chen

, et al. IL-6 and TNF-α induced obesity-related inflammatory response through transcriptional regulation of miR-146b. J Interferon Cytokine Res. 2014;34(5):342-348. doi:10.1089/jir.2013.0078

Valenzuela

Saco-Ledo

Santos-Lozano

, et al. Exercise training and natural killer cells in cancer survivors: current evidence and research gaps based on a systematic review and meta-analysis. Sports Med Open. 2022;8(1):36. doi:10.1186/s40798-022-00419-w

Hojman

Gehl

Christensen

Pedersen

. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 2018;27(1):10-21. doi:10.1016/j.cmet.2017.09.015

Di Daniele

Noce

Vidiri

, et al. Impact of mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget. 2017;8(5):8947-8979. doi:10.18632/oncotarget.13553

Sanft

Harrigan

McGowan

, et al. Randomized trial of exercise and nutrition on chemotherapy completion and pathologic complete response in women with breast cancer: the lifestyle, exercise, and nutrition early after diagnosis study. J Clin Oncol. 2023;41(34):5285-5295. doi:10.1200/jco.23.00871

Emerson

Sciarrillo

Kurti

Emerson

Rosenkranz

. High-fat meal–induced changes in markers of inflammation and angiogenesis in healthy adults who differ by age and physical activity level. Curr Dev Nutr. 2019;3(1):nzy098.

Carmeliet

. Angiogenesis in life, disease and medicine. Nature. 2005;438(7070):932-936. doi:10.1038/nature04478

Park

Morley

Kim

Clegg

Scherer

. Obesity and cancer--mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10(8):455-465. doi:10.1038/nrendo.2014.94

10.

Fuster

Ouchi

Gokce

Walsh

. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118(11):1786-18007. doi:10.1161/circresaha.115.306885

11.

Mair

Gaw

MacLean

. Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension. Pulm Circ. 2020;10(3):2045894020952019. doi:10.1177/2045894020952023

12.

Tan

Shi

Tang

Han

Spivack

. Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells. J Nutr. 2010;140(8):1404-1410. doi:10.3945/jn.110.121905

13.

Oak

El Bedoui

Schini-Kerth

. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem. 2005;16(1):1-8. doi:10.1016/j.jnutbio.2004.09.004

14.

Briguglio

Costa

Pollicino

Giambò

Catania

Fenga

. Polyphenols in cancer prevention: new insights. Int J Funct Nutr. 2020;1(2):9. doi:10.3892/ijfn.2020.9

15.

Bloor

. Angiogenesis during exercise and training. Angiogenesis. 2005;8(3):263-267. doi:10.1007/s10456-005-9013-x

16.

Ioniță-Mîndrican

Ziani

Mititelu

, et al. Therapeutic benefits and dietary restrictions of fiber intake: a state of the art review. Nutrients. 2022;14(13):2641. doi:10.3390/nu14132641

17.

Bandera

Kushi

Moore

Gifkins

McCullough

. Association between dietary fiber and endometrial cancer: a dose-response meta-analysis. Am J Clin Nutr. 2007;86(6):1730-1737. doi:10.1093/ajcn/86.5.1730

18.

Law

Habibi

, et al. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Res. 2008;68(24):10238-10246. doi:10.1158/0008-5472.Can-08-2755

19.

Sidorkiewicz

Jóźwik

Niemira

Krętowski

. Insulin resistance and endometrial cancer: emerging role for microRNA. Cancers (Basel). 2020;12(9):20200908. doi:10.3390/cancers12092559

20.

Gascón

Valle

Martos

, et al. Sex hormone-binding globulin as a marker for hyperinsulinemia And/Or insulin resistance in Obese children. Eur J Endocrinol. 2000;143(1):85-89. doi:10.1530/eje.0.1430085

21.

Heckman-Stoddard

DeCensi

Sahasrabuddhe

Ford

. Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia. 2017;60(9):1639-1647. doi:10.1007/s00125-017-4372-6

22.

Zheng

Lin

Chen

, et al. Gut microbiota and endometrial cancer: research progress on the pathogenesis and application. Ann Med. 2025;57(1):2451766. doi:10.1080/07853890.2025.2451766

23.

Zhang

. Influence of foods and nutrition on the gut microbiome and implications for intestinal health. Int J Mol Sci. 2022;23(17):9588. doi:10.3390/ijms23179588

24.

Al-Qadami

Secombe

Subramaniam

Wardill

Bowen

. Gut microbiota-derived short-chain fatty acids: impact on cancer treatment response and toxicities. Microorganisms. 2022;10(10):2048. doi:10.3390/microorganisms10102048

25.

Kang

Trevaskis

Murphy

Febbraio

. Diet-induced gut dysbiosis and inflammation: key drivers of obesity-driven NASH. iScience. 2023;26(1):105905. doi:10.1016/j.isci.2022.105905

26.

Demark-Wahnefried

Schmitz

Alfano

, et al. Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin. 2018;68(1):64-89. doi:10.3322/caac.21441

27.

Tuinman

Nuver

de Boer

Looijmans

Hagedoorn

. Lifestyle changes after cancer treatment in patients and their partners: a qualitative study. Support Care Cancer. 2024;32(4):248. doi:10.1007/s00520-024-08447-w

28.

Ferioli

Zauli

Martelli

, et al. Impact of physical exercise in cancer survivors during and after antineoplastic treatments. Oncotarget. 2018;9(17):14005-14034. doi:10.18632/oncotarget.24456

29.

Cole

Kleckner

Jatoi

Schwarz

Dunne

. The role of systemic inflammation in cancer-associated muscle wasting and rationale for exercise as a therapeutic intervention. JCSM Clin Rep. 2018;3(2):e00065.

30.

Freitas

RDS

Campos

. Protective effects of Omega-3 fatty acids in cancer-related complications. Nutrients. 2019;11(5):20190426. doi:10.3390/nu11050945

31.

Laviano

Rianda

Molfino

Rossi Fanelli

. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care. 2013;16(2):156-161. doi:10.1097/MCO.0b013e32835d2d99

32.

Mustian

Sprod

Palesh

, et al. Exercise for the management of side effects and quality of life among cancer survivors. Curr Sports Med Rep. 2009;8(6):325-330. doi:10.1249/JSR.0b013e3181c22324

33.

Misiąg

Piszczyk

Szymańska-Chabowska

Chabowski

. Physical activity and cancer Care-A review. Cancers (Basel). 2022;14(17):4154. doi:10.3390/cancers14174154

34.

Segal

Zwaal

Green

Tomasone

Loblaw

Petrella

. Exercise for people with cancer: a clinical practice guideline. Curr Oncol. 2017;24(1):40-46. doi:10.3747/co.24.3376

35.

Brown

Gilmore

. Physical activity reduces the risk of recurrence and mortality in cancer patients. Exerc Sport Sci Rev. 2020;48(2):67-73. doi:10.1249/jes.0000000000000214

36.

Haskins

Champ

Miller

Vyfhuis

MAL

. Nutrition in cancer: evidence and equality. Adv Radiat Oncol. 2020;5(5):817-823. doi:10.1016/j.adro.2020.05.008

37.

Kunzler

Helmreich

König

, et al. Psychological interventions to foster resilience in healthcare students. Cochrane Database Syst Rev. 2020;7(7):Cd013684. doi:10.1002/14651858.Cd013684

38.

Mazza

Troiano

Ferro

, et al. Obesity, dietary patterns, and hormonal balance modulation: gender-specific impacts. Nutrients. 2024;16(11):1629. doi:10.3390/nu16111629

39.

Rundle-Thiele

Shrestha

Janda

. Prevention of endometrial cancer through lifestyle interventions: a systematic review and synthesis. Gynecol Oncol Rep. 2022;39:100900. doi:10.1016/j.gore.2021.100900

40.

Beavis

Smith

Fader

. Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health. 2016;8:151-167. doi:10.2147/ijwh.S88367

41.

Moorman

Jones

Akushevich

Schildkraut

. Recreational physical activity and ovarian cancer risk and survival. Ann Epidemiol. 2011;21(3):178-187. doi:10.1016/j.annepidem.2010.10.014

42.

Wanjau

Möller

Haigh

, et al. Physical activity and depression and anxiety disorders: a systematic review of reviews and assessment of causality. AJ Focus. 2023;2(2):100074. doi:10.1016/j.focus.2023.100074

43.

Smits

Lopes

Das

Bekkers

Massuger

Galaal

. The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors: a systematic review and meta-analysis. Gynecol Oncol. 2015;139(3):546-552. doi:10.1016/j.ygyno.2015.10.002

44.

Mustian

Sprod

Janelsins

Peppone

Mohile

. Exercise recommendations for cancer-related fatigue, cognitive impairment, sleep problems, depression, pain, anxiety, and physical dysfunction: a review. Oncol Hematol Rev. 2012;8(2):81-88. doi:10.17925/ohr.2012.08.2.81

45.

Nutrition in Cancer Care: Patient Version. PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002.

46.

Muscaritoli

Lucia

Farcomeni

, et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget. 2017;8(45):79884. doi:10.18632/oncotarget.20168

47.

Thomson

Crane

Miller

, et al. Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors. Gynecol Oncol. 2023;170:11-18. doi:10.1016/j.ygyno.2022.12.017

48.

Courneya

Vardy

O'Callaghan

, et al. Structured exercise after adjuvant chemotherapy for Colon cancer. N Engl J Med. 2025;393(1):13-25. doi:10.1056/NEJMoa2502760

49.

Hansen

Nagle

Ibiebele

, et al. A healthy lifestyle and survival among women with ovarian cancer. Int J Cancer. 2020;147(12):3361-3369. doi:10.1002/ijc.33155

50.

Nagle

Ibiebele

, et al. Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the ovarian cancer association consortium. Am J Clin Nutr. 2025;121(4):758-768. doi:10.1016/j.ajcnut.2025.02.004

51.

Spei

Samoli

Bravi

La Vecchia

Bamia

Benetou

. Physical activity in breast cancer survivors: a systematic review and meta-analysis on overall and breast cancer survival. Breast. 2019;44:144-152. doi:10.1016/j.breast.2019.02.001

52.

McKenzie

Ahmad

. Impact of lifestyle interventions on gynecologic cancers: beyond diet and exercise. Am J Lifestyle Med. 2024;18(1):7-20. doi:10.1177/15598276221123764

53.

Spanoudaki

Giaginis

Karafyllaki

, et al. Exercise as a promising agent against cancer: evaluating its anti-cancer molecular mechanisms. Cancers (Basel). 2023;15(21):5135. doi:10.3390/cancers15215135

54.

Hajat

MacLehose

Rosofsky

Walker

Clougherty

. Confounding by socioeconomic status in epidemiological studies of air pollution and health: challenges and opportunities. Environ Health Perspect. 2021;129(6):65001. doi:10.1289/ehp7980

55.

Hébert

Frongillo

Adams

, et al. Perspective: randomized controlled trials are not a panacea for diet-related research. Adv Nutr. 2016;7(3):423-432. doi:10.3945/an.115.011023

56.

Raihan

Cogburn

57.

Lawrance

McLeroy

. Self-efficacy and health education. J Sch Health. 1986;56(8):317-321. doi:10.1111/j.1746-1561.1986.tb05761.x

58.

Nezami

Lang

Jakicic

, et al. The effect of self-efficacy on behavior and weight in a behavioral weight-loss intervention. Health Psychol. 2016;714-722. doi:10.1037/hea0000378

59.

Reblin

Uchino

. Social and emotional support and its implication for health. Curr Opin Psychiatr. 2008;21(2):201-205. doi:10.1097/YCO.0b013e3282f3ad89

60.

Hashemzadeh

Rahimi

Zare-Farashbandi

Alavi-Naeini

Daei

. Transtheoretical model of health behavioral change: a systematic review. Iran J Nurs Midwifery Res. 2019;24(2):83-90. doi:10.4103/ijnmr.IJNMR_94_17

61.

Noordman

de Vet

van der Weijden

van Dulmen

. Motivational interviewing within the different stages of change: an analysis of practice nurse-patient consultations aimed at promoting a healthier lifestyle. Soc Sci Med. 2013;87:60-67. doi:10.1016/j.socscimed.2013.03.019

62.

Ligibel

Alfano

Hershman

, et al. Exercise, diet, and weight management during cancer treatment: ASCO guideline. J Clin Oncol. 2022;40(24):2491-2507. doi:10.1200/JCO.22.00687

63.

Rock

Thomson

Sullivan

, et al. American cancer society nutrition and physical activity guideline for cancer survivors. CA Cancer J Clin. 2022;72(3):230-262. doi:10.3322/caac.21719

64.

U.S. Preventive Services Task Force Curry

Krist

, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: USPSTF recommendation statement. JAMA. 2018;320(11):1163-1171. doi:10.1001/jama.2018.13022

65.

von Gruenigen

Frasure

Kavanagh

Lerner

Waggoner

Courneya

. Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy. Gynecol Oncol. 2011;122(2):328-333. doi:10.1016/j.ygyno.2011.04.043

66.

von

. Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): adherence and weight outcomes. Gynecol Oncol. 2012;125(3):699-704. doi:10.1016/j.ygyno.2012.03.04

67.

Morris

Kosmacki

Tolby

, et al. Integration of a lifestyle modification intervention for women with overweight and obesity in a gynecologic oncology practice. Gynecol Oncol. 2025;196:168-174. doi:10.1016/j.ygyno.2025.04.516

68.

Demark-Wahnefried

Aziz

Rowland

Pinto

. Practical clinical interventions for diet, physical activity, and weight control in survivors of cancer. CA Cancer J Clin. 2015;65(3):167-189. doi:10.3322/caac.2126

69.

Yeganeh

. The effects of lifestyle and behavioural interventions on cancer recurrence, survival and quality of life in breast cancer survivors: a systematic review. Eur J Oncol Nurs. 2024;67:102450. doi:10.1016/j.ejon.2024.102450

70.

Viamonte

Joaquim

Alves

, et al. Cardio-oncology rehabilitation for cancer survivors with high cardiovascular risk: a randomized clinical trial. JAMA Cardiol. 2023;8(12):1119-1128. doi:10.1001/jamacardio.2023.3558

71.

Roberts

Fisher

Smith

Heinrich

Potts

HWW

. Digital health behaviour change interventions targeting physical activity and diet in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2017;11(6):704-719. doi:10.1007/s11764-017-0632-1

72.

Chatterjee

Prinz

Gerdes

Martinez

. Digital interventions on healthy lifestyle management: systematic review. J Med Internet Res. 2021;23(11):e26931. doi:10.2196/26931

73.

Kang

Exworthy

. Wearing the future-wearables to empower users to take greater responsibility for their health and care: scoping review. JMIR mHealth uHealth. 2022;10(7):e35684. doi:10.2196/35684

74.

Bélanger-Gravel

Godin

Vézina-Im

Amireault

Poirier

. Effective behaviour change techniques for physical activity and healthy eating in overweight and Obese adults: systematic review and meta-regression analyses. Int J Behav Nutr Phys Activ. 2017;14(1):42. doi:10.1186/s12966-017-0494-y

75.

Villinger

Wahl

Boeing

Schupp

Renner

. The effectiveness of app-based Mobile interventions on nutrition behaviours and nutrition-related health outcomes: systematic review and meta-analysis. J Med Internet Res. 2019;21(5):e13088. doi:10.2196/13088

76.

Bantham

Taverno Ross

Sebastião

Hall

. Overcoming barriers to physical activity in underserved populations. Prog Cardiovasc Dis. 2021;64:64-71. doi:10.1016/j.pcad.2020.11.002

77.

Pampel

Krueger

Denney

. Socioeconomic disparities in health behaviors. Annu Rev Sociol. 2010;36:349-370. doi:10.1146/annurev.soc.012809.102529

78.

Saeed

Masters

. Disparities in health care and the digital divide. Curr Psychiatry Rep. 2021;23(9):61. doi:10.1007/s11920-021-01274-4

79.

Middleton

Anton

Perri

. Long-term adherence to health behavior change. Am J Lifestyle Med. 2013;7(6):395-404. doi:10.1177/1559827613488867

80.

Stecher

Pfisterer

Harden

, et al. Assessing the pragmatic nature of Mobile health interventions promoting physical activity: systematic review and meta-analysis. JMIR mHealth uHealth. 2023;11:e43162. doi:10.2196/43162

81.

Ormel

van der Schoot

GGF

Westerink

Sluiter

Gietema

Walenkamp

AME

. Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial). Support Care Cancer. 2018;26(11):3915-9623. doi:10.1007/s00520-018-4263-5

82.

Cadmus-Bertram

Marcus

Patterson

Parker

Morey

. Randomized trial of a fitbit-based physical activity intervention for women. Am J Prev Med. 2015;49(3):414-418. doi:10.1016/j.amepre.2015.01.020

83.

Mannoubi

Kairy

Menezes

Desroches

Layani

Vachon

. The key digital tool features of complex telehealth interventions used for type 2 diabetes self-management and monitoring with health professional involvement: scoping review. JMIR Med Inform. 2024;12:e46699. doi:10.2196/46699

84.

Saeidi

Ghavami

Shahsavari

Siabani

Rajati

. The effect of trans-theoretical model stage-matched intervention on medication adherence in hypertensive patients. Front Cardiovasc Med. 2024;11:1470666. doi:10.3389/fcvm.2024.1470666

85.

Imeri

Toth

Arnold

Barnard

. Use of the transtheoretical model in medication adherence: a systematic review. Res Soc Adm Pharm. 2022;18(5):2778-2785. doi:10.1016/j.sapharm.2021.07.008